Just saw an interview with Dr. Ramin Oskoui (credentials

New Post Public Reply Private Reply Replies (1) Message Board
homerbedloe
500
Just saw an interview with Dr. Ramin Oskoui (credentials below - John Hopkins) that was discussing vaccines. He just stated that (and I'm trying to quote what he said by typing while watching a DVR recording his discussion) "the problem with these vaccines (he was speaking of Moderna, Oxford, others) is we don't know how long the antibodies will last and whether they're effective. What concerns me is none of these vaccine makers are looking at innate T Cell immunity - the T Cell is very important in this viral response...and I don't see any metric by these vaccine makers that are measuring this. And that's really the important question to ask; how long will this immunity last, and what are we showing in terms of T Cell training to fight future viral infections, or this viral infection when the vaccine is given."

Sound familiar?

I also saw an interview with Dr. Oz (yeah, I know, a TV doc) that did not specifically mention T Cells, but did question how long the immunity response from the Moderna/Oxford vaccines will last. He said he had a number of vaccine makers on his show, and while he was optimistic, there was no way to have a vaccine by fall, but potentially by 1st of year although there may be no long term immunity provided.

This independently confirms everything Joe and Dr. EVH have talked about re: a complete vaccine. Wonder if Joe and team might contact Dr. Oskoui to discuss NGIO's approach with the T Cell long term response?

https://www.hopkinsmedicine.org/profiles/resu...min-oskoui

Or maybe speak to Dr. Oz and potentially go on his show to discuss the NGIO approach?

Probably both are prohibited until BARDA makes a decision re: funding. But these discussions do show a weakness that most don't understand when the news headlines show Moderna is in final test phase or Oxford had a full antibody response to their RNA/mRNA vaccines.

So keep the faith that NGIO/GNBT's approach is still valid, and in some ways, is WAY ahead of the game per some very smart independent Doctors - that is, if you choose not to believe Joe or Dr. EVH.

Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hudsonville's Leadership Shift Eyes the Future

Updated Category News Views 168

Hudsonville's New Chapter: Enter CJ Ellens When a firm as storied as Hudsonville Ice Cream elects a new captain at the helm, folks sit up and take notice. CJ Ellens, already well-embedded in the fabric of Hudsonville, is set to steer the ship starting January 1, 2027. This isn't just a revolving door of C-suites, but more like a passing of the torch to someone bred in the...

Continue Reading
Young Talent Tackles IVF & Air Pollution Research

Updated Category News Views 81

Rookie Researcher: Jeffrey's Bold Leap at ASRM 2026 Teenagers typically have their heads buried in textbooks, but Jeffrey Huang's got his eyes set on something bigger. This high school junior from Taipei American School leaped onto the international stage at the American Society for Reproductive Medicine (ASRM) 2026, carrying a scientific study centred on a critical...

Continue Reading
LG Energy Solution's Q3 2026: Power Moves in ESS Expansion

Updated Category News Views 103

LG's Strategic Battery Play You know it's serious when a company pushes into new territories with gusto. LG Energy Solution isn’t tiptoeing with their recent financials—Q3 2026 showed 'em raking in KRW 9.6 trillion in revenue. That's a mighty 27.6% uptick from the previous quarter, no small potatoes by any stretch, especially when their operating profit stands solid...

Continue Reading
Beyon Expands Green Data Centres to Three Facilities

Updated Category News Views 57

Blazing Solar Trails in the Digital Landscape Lend an ear, folks, because Beyon's latest leap in the world of renewable energy isn't just another 'look how green we are' maneuver. Announced during Gateway Gulf 2026, this venture is all about serious numbers and even more serious energy chops. Beyon's on course to power a third data center entirely through solar energy,...

Continue Reading
AAR's $1.9B Notes Offering and Strategic Moves

Updated Category News Views 59

A Look at AAR's Bold Move Big moves often come with big price tags, and AAR Corp's recent announcement is no exception. The aviation aftermarket titan recently declared a hefty $1.9 billion offering of senior notes, divided between 7.125% notes due 2031 and 7.375% notes maturing in 2034. It's a leap that signals their intent to snag a controlling interest in MRO Holdings,...

Continue Reading
Webull's China Ties Spark Investor Lawsuit: Act Now

Updated Category News Views 35

Trouble in Tech Paradise? Webull Faces Heat Look, when a tech name like Webull Corporation (NASDAQ: BULL) lands in the courtroom, it's enough to raise the eyebrows of anyone keeping tabs on their portfolio. So here's the deal: Webull's deep-rooted connection to China has come under fire, and boy, this ain't just another blip on the investor's radar. The company's...

Continue Reading
Wolfbox Unveils High-Octane Gear at SEMA 2026

Updated Category News Views 88

Revving Up with Wolfbox's New Offerings There's an electrifying hum in the air, buzz-fueled by Wolfbox's latest gear debut at the SEMA Show 2026 in Las Vegas. The booth is a treasure trove for anyone keen on amping up their vehicle tech, with Wolfbox laying bare everything from dazzling dash cams to adaptive trail lights. It's the kind of smorgasbord that'd make a...

Continue Reading
Curaleaf Takes Stake in NJ's Boone Town Dispensary

Updated Category News Views 140

Curaleaf's Bold Move in the Garden State Curaleaf Holdings, Inc. is doubling down on its cannabis bet in New Jersey. The acquisition of an equity stake in Boone Town Provisions, located at 677 Myrtle Ave., Boonton, NJ, boosts Curaleaf’s dispensary count to four in the state. The company's not just wandering on the map; it's pinpointing high-performing locations to...

Continue Reading
Watches of Switzerland Dazzles with Holiday Campaign

Updated Category News Views 84

Swiss Timepieces Take Center Stage Ever feel like there's a certain art to gift-giving? Apparently, The Watches of Switzerland Group thinks so, and they're not holding back in showing us how it's done with their new 'Brilliantly Given' campaign. They’re taking a classic approach by spotlighting luxury timepieces and fine jewelry just in time for the holiday...

Continue Reading
PATEO Drives In-Car AI Forward with NVIDIA Power

Updated Category News Views 0

Revolutionizing In-Vehicle AI with Big Names Boy, driving ain't what it used to be, and PATEO's latest adventure has a lot to do about it. They've hooked up with some major players like NVIDIA and ByteDance to really shake up the in-car AI scene. We're not just talking bells and whistles, but a true reinvention trying to blend AI straight into our daily grind on the road....

Continue Reading

Top 5 Most Recently Viewed Articles

Vicor Launches Innovative Power Modules for Automotive Needs

Updated Category News Views 323

Vicor Introduces Groundbreaking Automotive-Grade Power Modules Vicor has recently unveiled a trio of advanced automotive-grade power modules that promise unmatched power density, fostering the widespread adoption of 48V zonal architectures in vehicles. This innovative product line includes the BCM6135, DCM3735, and PRM3735, each designed to support 48V power distribution,...

Continue Reading
NACD Board Welcomes Industry Veterans to Strengthen Governance

Updated Category News Views 226

Leadership Changes at NACD Enhance Board Effectiveness Industry veterans bring a wealth of knowledge in governance and innovation. In a landmark move, the National Association of Corporate Directors (NACD) has strengthened its board with the appointments of Jesús Mantas and Wes Bricker. Both distinguished leaders are set to enhance the governance and strategic leadership...

Continue Reading
APLA Health Unveils Significant Growth at Long Beach Center

Updated Category News Views 138

APLA Health Celebrates a New Milestone Mayor Rex Richardson and Community Leaders Join Grand Reopening Celebration APLA Health is excited to announce the grand reopening of its Long Beach Health Center, following a significant expansion aimed at improving healthcare access for the LGBTQ+ community and other underserved populations. The expanded facility is a testament to...

Continue Reading
Apnimed's AD109 Phase 3 Trial Results Highlight Game-Changer

Updated Category News Views 347

Breakthrough in Obstructive Sleep Apnea Treatment with AD109 Apnimed, a clinical-stage pharmaceutical company, has recently made headlines with positive topline results from its second Phase 3 trial of AD109, known as LunAIRo. This trial has demonstrated substantial efficacy in addressing obstructive sleep apnea (OSA), reinforcing the potential of AD109 as the first oral...

Continue Reading
Castle Biosciences Faces Stock Decline Amidst New Challenges

Updated Category News Views 215

Castle Biosciences Stock Performance Overview Castle Biosciences, Inc. (NASDAQ: CSTL) has recently seen a notable decline in its stock price, falling 14% in a single day. This drop is primarily attributed to mixed reactions to the company’s preliminary performance and the implications of a recent ruling by a key payer. Although the firm announced that it expects to meet...

Continue Reading